These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5933553)

  • 21. Pharmacology of hypertension with special reference to the cardiovascular effects of beta-adrenergic blocking agents.
    Aviado DM
    Adv Cardiopulm Dis; 1969; 4():129-44. PubMed ID: 5762786
    [No Abstract]   [Full Text] [Related]  

  • 22. [Essential hypertension: current therapeutic approach].
    Manzi M; Santarossa C; Feriozzi S
    Clin Ter; 1982 Feb; 100(4):337-57. PubMed ID: 6177467
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sympathomimetics in ADHD. Cardiovascular risks, FDA warns].
    Ostman-Smith I; Dellborg M
    Lakartidningen; 2007 Apr 25-May 1; 104(17):1307. PubMed ID: 17547274
    [No Abstract]   [Full Text] [Related]  

  • 24. [Beta receptor antagonists--pharmacologic characteristics and mechanism of action in cardiovascular diseases].
    Langnickel R; Bluth R
    Z Arztl Fortbild (Jena); 1984; 78(7):255-61. PubMed ID: 6145258
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blockade of beta receptors in clinical pharmacology and therapy].
    Gersmeyer EF; Spitzbarth H
    Med Welt; 1967 Apr; 13():764-80. PubMed ID: 5584453
    [No Abstract]   [Full Text] [Related]  

  • 26. Comprehensive drug management of hypertension.
    Oparil S; Winternitz S
    Cardiovasc Clin; 1984; 14(3):73-91. PubMed ID: 6144392
    [No Abstract]   [Full Text] [Related]  

  • 27. [Beta blockers in pediatric cardiology].
    Gérard R; Gatau-Pelanchon J; Faugère G
    Arch Mal Coeur Vaiss; 1980 May; 73(5):449-54. PubMed ID: 6104950
    [No Abstract]   [Full Text] [Related]  

  • 28. Beta-adrenergic blockade in the management of acute thyrotoxic crisis, tachycardia and arrhythmias.
    Parsons V; Jewitt D
    Postgrad Med J; 1967 Dec; 43(506):756-62. PubMed ID: 6079199
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapy with sympatholytics].
    Schweitzer P
    Lek Veda Zahr; 1967 Dec; 12():225-31. PubMed ID: 4874499
    [No Abstract]   [Full Text] [Related]  

  • 30. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
    Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular consequences of sympathetic hyperactivity.
    Leenen FH
    Can J Cardiol; 1999 Mar; 15 Suppl A():2A-7A. PubMed ID: 10205250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy of hypertension: 1980.
    Hall WD
    J Med Assoc Ga; 1980 Sep; 69(9):745-8. PubMed ID: 6106659
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hyperdynamic beta-adrenergic circulatory state with arterial hypertension].
    Caralps A; Martínez-Muñóz A
    Rev Clin Esp; 1973 Jun; 129(5):507-10. PubMed ID: 4732997
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of high blood pressure. From diuretics to the present and future.
    Nogueira da Costa J
    Cardiologia; 1995 Dec; 40(12):893-8. PubMed ID: 8901039
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic use of beta-adrenergic blocking agents].
    Renner C; Rouffy J
    Presse Med (1893); 1967 Jul; 75(32):1651-3. PubMed ID: 6027505
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study of circulatory changes caused by 2-(N-p'-tolyl-N-(m'-hydroxyphenyl)-aminomethyl)-imidazoline].
    BUTTO M; MASETTO I
    Minerva Med; 1954 Feb; 45(17):583-5. PubMed ID: 13165203
    [No Abstract]   [Full Text] [Related]  

  • 37. [Indications for adrenergic beta blockaders. 2].
    Larochelle P; Lelorier J
    Union Med Can; 1981 Aug; 110(8):697-9. PubMed ID: 6117145
    [No Abstract]   [Full Text] [Related]  

  • 38. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
    Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
    Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of essential arterial hypertension. IV. Drugs with peripheral sympathetic action].
    Fossati C
    Clin Ter; 1980 May; 93(4):457-79. PubMed ID: 6106537
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyperdynamic beta-adrenergic syndrome among Croatian soldiers engaged in battle.
    Heitzler VN; Bergovec M; Prpić H; Tomljenović M; Stancić V; Gopcević A; Mihatov S; Seni B; Beslin MB; Eremić Z
    Wien Med Wochenschr; 1993; 143(18):479-81. PubMed ID: 8310702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.